pharmaceutical regulations
Drug Safety Management in Japan: An Update on Current and Future Regulations
August 11 by Pharma IQJapan's pharmaceutical market is the second largest in the world but has long suffered from the so-called drug lag. Lengthy approval processes for drugs have seen medicines readily available...
Pharmaceutical Revenues under Threat - The Impact of Expected Major Changes and New Regulations
March 25 by Cristina FalcãoBased on new regulations, increased costs of R & D, the expiration of dozens of patents, the lack of future ‘cash cows’, the new transparency rules and the value-based pricing, pharmaceutical comp...
Triple Impact: 3 Regulations that Could Have a Big Bearing on Pharma in 2011
March 17 by Andrea CharlesRegulatory guidelines are having a huge impact on new pharmaceutical development. With more emphasis on patient safety than ever before, the number of new drugs being approved has been reduced. ...
DIA's Yves Juillet Speaks to Pharma IQ about the Road to Convergence
April 24 by Dr. Yves JuilletDr. Yves Juillet, DIA President, speaks to Pharma IQ, about the top 3 regulations impacting pharma in 2011 -2012 at DIA's 47th Annual Meeting. Juillet discusses the DIA's top priorities...